Related Articles
Sex comb on midleg like‑2 is a novel specific marker for the diagnosis of gastroenteropancreatic neuroendocrine tumors
Correlation between clinicopathological characteristics and the clinical prognosis of patients with gastroenteropancreatic neuroendocrine tumors
Expression of IMP3 as a marker for predicting poor outcome in gastroenteropancreatic neuroendocrine neoplasms
Compound gastroenteropancreatic neuroendocrine and gastrointestinal stromal tumors in the stomach: A case report
Somatostatin receptor expression indicates improved prognosis in gastroenteropancreatic neuroendocrine neoplasm, and octreotide long‑acting release is effective and safe in Chinese patients with advanced gastroenteropancreatic neuroendocrine tumors